Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort
- PMID: 19937601
- PMCID: PMC3404892
- DOI: 10.1002/humu.21114
Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort
Abstract
Mutations in the DMD gene, encoding the dystrophin protein, are responsible for the dystrophinopathies Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD), and X-linked Dilated Cardiomyopathy (XLDC). Mutation analysis has traditionally been challenging, due to the large gene size (79 exons over 2.2 Mb of genomic DNA). We report a very large aggregate data set comprised of DMD mutations detected in samples from patients enrolled in the United Dystrophinopathy Project, a multicenter research consortium, and in referral samples submitted for mutation analysis with a diagnosis of dystrophinopathy. We report 1,111 mutations in the DMD gene, including 891 mutations with associated phenotypes. These results encompass 506 point mutations (including 294 nonsense mutations) and significantly expand the number of mutations associated with the dystrophinopathies, highlighting the utility of modern diagnostic techniques. Our data supports the uniform hypermutability of CGA>TGA mutations, establishes the frequency of polymorphic muscle (Dp427m) protein isoforms and reveals unique genomic haplotypes associated with "private" mutations. We note that 60% of these patients would be predicted to benefit from skipping of a single DMD exon using antisense oligonucleotide therapy, and 62% would be predicted to benefit from an inclusive multiexonskipping approach directed toward exons 45 through 55.
Figures



Similar articles
-
Comprehensive genetic characteristics of dystrophinopathies in China.Orphanet J Rare Dis. 2018 Jul 4;13(1):109. doi: 10.1186/s13023-018-0853-z. Orphanet J Rare Dis. 2018. PMID: 29973226 Free PMC article.
-
Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy.Hum Genet. 2020 Feb;139(2):247-255. doi: 10.1007/s00439-019-02107-4. Epub 2020 Jan 9. Hum Genet. 2020. PMID: 31919629 Free PMC article.
-
DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations.PLoS One. 2015 Aug 18;10(8):e0135189. doi: 10.1371/journal.pone.0135189. eCollection 2015. PLoS One. 2015. PMID: 26284620 Free PMC article.
-
An Updated Analysis of Exon-Skipping Applicability for Duchenne Muscular Dystrophy Using the UMD-DMD Database.Genes (Basel). 2024 Nov 20;15(11):1489. doi: 10.3390/genes15111489. Genes (Basel). 2024. PMID: 39596689 Free PMC article. Review.
-
Advances in Dystrophinopathy Diagnosis and Therapy.Biomolecules. 2023 Aug 28;13(9):1319. doi: 10.3390/biom13091319. Biomolecules. 2023. PMID: 37759719 Free PMC article. Review.
Cited by
-
A defect in dystrophin causes a novel porcine stress syndrome.BMC Genomics. 2012 Jun 12;13:233. doi: 10.1186/1471-2164-13-233. BMC Genomics. 2012. PMID: 22691118 Free PMC article.
-
Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model.Skelet Muscle. 2024 Oct 1;14(1):21. doi: 10.1186/s13395-024-00353-3. Skelet Muscle. 2024. PMID: 39354597 Free PMC article.
-
Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).J Child Neurol. 2010 Sep;25(9):1158-64. doi: 10.1177/0883073810371129. Epub 2010 Jun 2. J Child Neurol. 2010. PMID: 20519671 Free PMC article. Review.
-
Combining Protein Expression and Molecular Data Improves Mutation Characterization of Dystrophinopathies.Front Neurol. 2021 Dec 7;12:718396. doi: 10.3389/fneur.2021.718396. eCollection 2021. Front Neurol. 2021. PMID: 34950096 Free PMC article.
-
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice.Nat Med. 2014 Sep;20(9):992-1000. doi: 10.1038/nm.3628. Epub 2014 Aug 10. Nat Med. 2014. PMID: 25108525 Free PMC article.
References
-
- Aartsma-Rus A, Fokkema I, Verschuuren J, Ginjaar I, van Deutekom J, van Ommen GJ, den Dunnen JT. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum Mutat. 2009;30(3):293–9. - PubMed
-
- Aartsma-Rus A, Janson AA, Kaman WE, Bremmer-Bout M, den Dunnen JT, Baas F, van Ommen GJ, van Deutekom JC. Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum Mol Genet. 2003;12(8):907–14. - PubMed
-
- Aartsma-Rus A, Van Deutekom JC, Fokkema IF, Van Ommen GJ, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 2006;34(2):135–44. - PubMed
-
- Antonarakis SE, Krawczak M, Cooper DN. Disease-causing mutations in the human genome. Eur J Pediatr. 2000;159(Suppl 3):S173–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous